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While the pathogenic mechanisms of Parkinson's disease (PD)
remain elusive, increasing evidence suggests that neurodegeneration
in PD is associated with impaired mitochondrial ‘quality control’ — an
imbalance between biogenesis and removal by autophagy. PD has
also been associated with impaired mitochondrial complex I activity
and complex I inhibitors like the neurotoxin rotenone cause
pathological and neurochemical changes with a remarkable similarity
to PD [1]. Rosiglitazone is a member of thiazolidinediones (TZDs),
used clinically as insulin-sensitizing drugs. These compounds selec-
tively bind to peroxisome proliferator-activated receptor gamma
(PPARg) a nuclear receptor and ligand-dependent transcription factor
that regulates the expression of several genes involved in lipid
and carbohydrate metabolism, upregulates antioxidant defences and
promotes mitochondrial biogenesis and has anti-inﬂammatory
properties [2]. PPARg agonists provide protection in several in vitro
and in vivo models of neurodegenerative disorders [3,4], but the
mechanism of protection is not clear. We have studied whether
rosiglitazone prevents mitochondrial damage of differentiated
human neuroblastoma SH-SY5Y cells exposed to rotenone and have
explored the interaction of biogenesis, autophagy and oxidative stress
pathways in neuroprotection. Our data show that chronic partial
inhibition of complex I in differentiated SH-SY5Y cells by rotenone
decreases mitochondrial mass and membrane potential, while
increasing autophagy and free radical generation. All these changes
were reversed by co-treatment of the cells with rosiglitazone, which
increased mitochondrial biogenesis and decreased autophagy and
free radical generation. Our data indicate that rosiglitazone is
potentially neuroprotective, acting directly on mitochondrial function
in neurons, and not indirectly by suppressing inﬂammation, and
might provide a valuable therapeutic strategy for the treatment of
progressive neurodegenerative disease such as Parkinson's disease.
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The respiratory chain of mitochondria produces the main amount
of the cellular ATP. To maintain the function of this machinerymost of
its proteins have to be imported into mitochondria after their
synthesis in the cytosol. Although most soluble mitochondrial
proteins contain a mitochondrial targeting signal (MTS), many of
the proteins of the IMS do not contain a MTS but instead are imported
by an oxidative folding mechanism [1,2]. Examples of such proteins
are the so called twin-CX9C proteins that contain four conserved
cysteines. After translocation into the IMS two intramolecular
disulﬁde bonds are formed which contribute to the correct folding
and the retention of the proteins [3]. The machinery that facilitates
oxidation is composed of two main components, the essential
disease-related proteins Mia40 and ALR. Mia40 is an oxidoreductase
that interacts with the reduced and unfolded substrate proteins
and oxidizes them. Mia40 is reduced after this reaction, and it is
subsequently regenerated by ALR [4]. This pathway has so far been
almost exclusively characterized in yeast cells and on isolated
mitochondria. We aim to characterize the pathway and its regulation
in intact mammalian cells. In our experiments we could verify
the importance of Mia40 and ALR for import and assembly of proteins
of the twin-CX9C-family in intact cells. Surprisingly the import
machinery of Mia40 and ALR is quite robust and unaffected by
several mitochondrial stress conditions like the inhibition of respira-
tory chain complexes and limited oxygen availability. However,
contrary to in vitro data, the oxidative protein import depends on
the membrane potential; exhibiting similarities to the MTS-dependent
protein import. Despite the dependence on the proton gradient, both
import pathways exhibit signiﬁcant differences in the kinetics of
import. Import and processing of MTS-containing proteins is a fast
process that occurs co-translationally or in a very fast posttranslational
manner. Conversely, the substrates of Mia40 remain soluble in the
cytosol after synthesis, and are imported in a slow process that is
limited by the rate of Mia40-mediated oxidation.
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